Alzamend Neuro ALZN
NASDAQ ALZN
$1.31 -0.04 (-2.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Alzamend Neuro (ALZN) Capital Expenditures (2023 - 2025)

Updated

Alzamend Neuro (ALZN) reported Capital Expenditures of $210,000 for fiscal Q4 2025 (quarter ended Apr 30, 2025).

Analysis

Alzamend Neuro (ALZN) Capital Expenditures (2023 - 2025) Analysis & Trends

For FY2025 (ended Apr 30, 2025), Alzamend Neuro posted Capital Expenditures of $300,000, up 103.7% from FY2024.

  • Capital Expenditures has a three-year compound annual growth rate of 41.2% (FY2022 to FY2025).
  • By fiscal year, Capital Expenditures came in at $147,243 in FY2024 and $106,458 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Alzamend Neuro 6.51 Mn -8.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 210,000.00
Jul 31, 2024 90,000.00
Jul 31, 2023 147,243.00
API Access

Alzamend Neuro Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALZN&period=max&api_key=YOUR_API_KEY